In the News / Politics

Carfentanil Poses New Threat of Epidemic in Local Communities

By: Gabrielle Flavoni, PharmD Candidate c/o 2018 - Drug diversion has always been a golden target for our nation’s law…

10 years ago

Results of Largest Pharmacotherapy Smoking Cessation Trial Prompts Debate over Varenicline’s Black Box Warning

By: Nicollette Pacheco, PharmD Candidate c/o 2017 - It is an easy decision to include a black box warning on…

10 years ago

New Metformin Labeling Change Mandated by the FDA

By: Jack (Hongkai) Bao, PharmD Candidate 2018 - Metformin is an oral anti-hyperglycemic agent of the biguanide class and is…

10 years ago

Medication Delivery: There’s an App for That

By:  Caitlyn Cummings, Pharm.D. and Maria Marzella Mantione, Pharm.D., CGP, FAPhA - From ordering food to requesting transportation, we trust…

10 years ago

An Alternative for Pulmonary Hypertension Approved

By: Jack (Hongkai) Bao, Staff Editor - On December 21st 2015, the FDA approved selexipag (Uptravi®), marketed by Actelion Pharmaceuticals…

10 years ago

FDA Approves New Combo Pill Genvoya® for HIV-1 Infection

By: Alex Chu, Staff Writer - On November 5th 2015, the U.S Food and Drug Administration approved Genvoya®, a once…

10 years ago

Optimizing Drug Safety in the Operating Room

By: Maryam Ahmed, PharmD Candidate c/o 2016 - While hospitals are a place where people can get their ailments cured,…

10 years ago

Better Understanding the Link between Myasthenia Gravis and Diabetes

By: Jacqueline Chirico, PharmD Candidate c/o 2016 - Myasthenia gravis is an autoimmune disorder in which an antibody-mediated attack is…

10 years ago

Imlygic™, the First Oncolytic Viral Therapy in the US

By: Gabrielle Plaia, PharmD Candidate Class of 2016 - On Oct. 27 2015, the Food and Drug Administration announced the…

10 years ago

Dabigatran Antidote Provides New Option for Targeted Anticoagulant Reversal

By: Svetlana Akbasheva, Staff Editor - Dabigatran etexilate mesylate (Pradaxa®) is an oral anticoagulant that functions as a direct thrombin…

11 years ago